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INTRODUCTION
Ubiquitin-proteasome-system (UPS) and autophagy 
are two separate but interconnected protein degradation 
systems [1]. Ubiquitin binding protein p62, Sequestosome 
1 (SQSTM1), has been shown to be a bridge between UPS 
and lysosomal protein degradation [2, 3]. p62, especially 
when phosphorylated on Serine 349 (P-Ser349 p62), has 
high affinity to Keap1, and connect autophagy and UPS 
to Keap1/Nrf2 antioxidant and cell protective pathway 
[4]. Of interest, murine p62 (A170) has been cloned from 
macrophages as an oxidative stress-inducible protein [5]. 
p62 competes with Nrf2 for Keap1 interaction, preventing 
Nrf2 degradation [6]. Furthermore, Nrf2 upregulates p62 
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ABSTRACT
Phosphorylation of p62/SQSTM1 (p62) on Serine 349 (P-Ser349 p62) as well 
as proteasome dysfunction have been shown to activate the cell protective Keap1/
Nrf2 pathway. We showed previously that BAY 11-7085-induced human synovial 
fibroblast cell death includes autophagy and p62 downregulation. In this work, we 
have studied expression of P-Ser349 p62 in human synovial fibroblasts. Results 
showed that P-Ser349 p62 was not detected in synovial cell extracts unless cells were 
cultured in the presence of proteasome inhibitor (MG132). MG132 revealed P-Ser349 
p62 turnover, that was further increased by concomitant autophagy inhibition and 
markedly enhanced in serum starved cells. Starvation sensitized synovial fibroblasts 
to BAY 11-7085 while MG132 protected both non-starved and starved cells from BAY 
11-7085-induced cell death. Lentivirus mediated overexpression of phosphorylation-
mimetic p62 mutant S349E markedly protected synovial fibroblasts from BAY 11-
7085. Inhibitor of Keap1-P-S349 p62 interaction, K67, had synergistic effect with 
MG132. Starvation increased p62 molecular weight, that was reversed by serum and 
bovine serum albumin re-feeding. Furthermore, starvation markedly induced RAD23B. 
Increased endo-β-N-acetylglucosaminidase (ENGase) turnover was detected in 
starved synovial fibroblasts. PNGase F treatment produced faster migration p62 form 
in human synovial tissue extracts but starvation-like p62 form of higher molecular 
weight in synovial cell extracts. Co-transfection of NGLY1, with p62 or p62 mutants 
S349A and S349E markedly stabilized p62 expressions in HEK293 cells. Tunicamycin 
upregulated p62 and protected synovial fibroblasts from BAY 11-7085-induced cell 
death. These results showed that P-Ser349 p62 has pro-survival role in human 
synovial fibroblasts and that de-glycosylation events are involved in p62 turnover.
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making the positive feedback loop between them [7]. 
Human P-Ser349 p62 and mice analog phosphorylation on 
Serine 351 have the main roles in p62-Keap1 interaction 
[4, 8], respectively. Both p62 and Nrf2 have been 
shown as cytoprotective [9]. However, deregulated p62 
phosphorylation can lead to metabolic reprograming and 
cancer development [10]. Mutations in C-terminal of p62 
are common in Paget’s disease of bone patients [11] and 
recently discovered S349T mutation of p62 links Paget’s 
disease to Keap1/Nfr2 pathway [12]. Very recently, 
activation of p62-Keap1-Nrf2 axis was shown to suppress 
collagen-induced arthritis in mice, in which P-Ser349 p62 
was recognized as disease suppressive protein [13].
 We have shown previously that BAY 11-7085-induced 
human synovial fibroblast cell death includes autophagy and 
p62 downregulation [14]. In this work, we have studied the 
role of P-Ser349 p62 on human synovial fibroblast fate.
RESULTS
UPS inhibition reveals P-Ser349 p62 in human 
synovial fibroblasts: Significantly higher 
P-Ser349 p62 turnover in serum starved cells
P-Ser349 p62 was not detected in serum cultured 
(Figure 1A, line 1) or in serum starved human synovial 
fibroblast extracts (Figure 1A, line 7). However, P-Ser349 
p62 accumulated in cells cultured in the presence of 
proteasome inhibitor MG132 (Figure 1A, lines 3–6 
and 8–12). Different concentration of MG132 revealed 
that serum deprivation, a known inducer of autophagy 
and LC3B-II (Figure 1B) [15], significantly increased 
P-Ser349 p62 as well as p62 stabilization (Figure 1A, 
lines 2, 3 in comparison to lines 8, 9, respectively). These 
results showed that P-S349 p62 is quickly degraded by 
proteasome in human synovial fibroblasts, especially 
during serum starvation.
Autophagy inhibition further increases MG132-
stabilized P-Ser349 p62 in synovial fibroblasts 
To test the effect of autophagy on P-Ser349 p62 
degradation, cells were cultured in the presence of MG132 
and/or autophagy inhibitor MHY1485. MHY1485 is an 
mTOR agonist and autophagy inhibitor that prevents 
fusion of autophagosome with lysosome [16]. Results 
showed that, in comparison to MG132 effect, significantly 
increased accumulation of P-Ser349 p62 as well as of p62 
was detected when cells were exposed to concomitant 
MG132 and MHY1485 treatment (Figure 2, line 2 in 
comparison to line 4). Similar results were obtained if 
another autophagy inhibitor, NH4Cl, was used instead 
of MHY1485 (results not shown). However, statistical 
analysis of six different experiments showed that 
MHY1485 did not significantly increased P-Ser349 p62 
in serum starved and MG132 treated cells (Figure 2, line 6 
in comparison to line 8). These results showed that human 
synovial fibroblast P-S349 p62 and p62 are degraded by 
both proteasome and autophagy.
MG132 protects whereas serum starvation 
sensitizes synovial fibroblasts to BAY 
11-7085-induced cell death 
Synovial fibroblasts were cultured in the presence or 
absence of MG132 (Figure 3) and then BAY 11-7085 was 
added for additional 2 hours. MTS test showed that MG132 
markedly protected both serum cultured and serum starved 
cells from BAY 11-7085-induced cell death (Figure 3, 
line 2 in comparison to lines 3–7; line 8 in comparison 
to lines 9–13). However, serum starvation significantly 
sensitized synovial fibroblast to BAY 11-70085-induced 
cell death (Figure 3, lines 2 and 8 to be compared in serum 
cultured and serum starved cells, respectively). These 
results suggested that stabilization of P-S349 p62 and p62 
may have pro-survival effects in synovial fibroblasts.
Starvation induces RAD23B, a proteasome 
and NGLY1 interactive protein, and reversibly 
increases p62 molecular weight (MW). 
Starvation-induced higher MW p62 is mimicked 
by PNGase F
We observed that, upon serum deprivation, p62 
migrated slower on SDS gel (Figure 4A, lines 2,  7 and 12). 
Slower migrating p62 is shown by doted arrow. This p62 
form was not recognized by P-S349 p62 antibody (Figure 
1A, line 7 and Figure 2, line 5) and was not sensitive to λ 
protein phosphatase (data not shown). Concomitantly with 
increased p62 molecular weight (MW), serum deprivation 
also induced RAD23B, a proteasome and N-glycanase 1 
(NGLY1) interactive protein [17, 18] (Figure 4A, lines 
2, 7 and 12). In addition, both p62 increased MW and 
RAD23B expression were, within minutes, reversed with 
serum re-feeding (Figure 4A, lines 3,  8 and 13). Because 
NGLY1 is a human PNGase involved in endoplasmic-
reticulum-associated protein degradation (ERAD) [19], 
these results suggested that de-glycosylation events 
maybe involved in p62 MW modification and/or p62 
turnover. PNGase F treatment of denaturated synovial 
fibroblast extracts mimicked starvation-induced increase 
of p62 MW (Figure 4A, lines 5, 10 and 15). Of interest, 
p62 accumulated in synovial fibroblasts treated with 
tunicamycin, inhibitor of N-linked glycosylation (Figure 
4B). In addition, tunicamycin significantly protected cells 
from BAY 11-7085-induced cell death (Figure 4C, line 7 
compared to line 12). Furthermore, K67, inhibitor of both 
Keap1-P-S349 p62 interaction and Nrf2, that liberates 
Keap1 for its interaction with Nrf2 and stabilizes P-S349 
p62 [10, 20], had synergistic effect with low, sub protective 
concentration of MG132 (Figure 4C, line 7 compared to 
line 9). These results showed that P-S349 p62, p62 and 
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de-glycosylation events are positively involved in synovial 
fibroblast survival and that de-glycosylation events are 
involved in p62 turnover.
Lentivirus mediated expression of 
phosphorylation-mimetic p62 mutant (S349E) 
markedly protects human synovial fibroblasts 
from BAY 11-7085-induced cell death
To test the direct effects of P-S349 p62 on synovial 
fibroblast survival, we have transduced cells with 
lentiviruses carrying either phosphorylation-mimetic p62-
HA mutant (S349E), phosphorylation-defective p62-HA 
mutant (S349A), wild type p62-HA (WT) or control EGFP 
(GFP) (Figure 5A). Overexpression of phosphorylation-
mimetic p62-HA mutant (S349E) markedly protected 
synovial fibroblasts from BAY 11-7085-induced cell death 
(Figure 5B, lines 18 and 19 in comparison with lines 29 
and 30; Figure 5C), while phosphorylation-defective p62-
HA mutant (S349A) and wild type p62-HA were without 
effect (Figure 5B, lines 22, 23 and 26,27, respectively; 
Figure 5C). Furthermore, a partial knockdown of p62, 
using lentivirus expressing p62 shRNA, did not change cell 
fate upon BAY 11-7085 treatment (Figure 6A, 6B). These 
results showed a prominent role of p62 phosphorylation on 
Serine 349 in human synovial fibroblast survival.
Figure 1: Proteasome inhibitor reveals P-S349 p62 that increases during starvation in human synovial fibroblasts. 
(A) Human synovial fibroblasts were treated with different concentrations of proteasome inhibitor MG132 for 24 hours, in the presence 
or absence of 10% FCS.  Western blots show P-S349 p62, p62, LC3B and GAPDH expressions in human synovial fibroblast extracts. 
Graphics represent average of protein expression from three different experiments done with synovial fibroblasts from three different OA 
patients. Values were corrected for GAPDH expression and shown as a percentage of maximal protein expression. LC3B is shown as % of 
LC3BII/LC3BI ratio. a* is statistically lower from c*; b* is statistically lower from d*; e* is statistically lower from g*; f* is statistically lower 
from h*; i* is statistically lower from j*. (B) Autophagic flux were determined by Bafilomycin A1 treatment of synovial fibroblast for 24 
hours, at the indicated concentrations. Graphics represent % of autophagic flux calculated as increase of p62 expression in Bafilomycin (10 
µM) treated synovial fibroblasts obtained from three different OA patients. a* is statistically different from control cells and significantly 
lower than b*.
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OA human synovial fibroblasts constitutively 
express Nrf2 phosphorylated on Serine 40. 
MG132 increases Nrf2 expression
p62 phosphorylation on Serine 349 is known to 
activate Nfr2. We thus looked for Nrf2 and activated 
Nrf2 (i.e. phosphorylated on Serine 40) [21] in synovial 
fibroblasts that express P-S349 p62, upon MG132 treatment 
(Figure 6C). Results showed that while Nrf2 expression 
increased with MG132 concentration, phosphorylated Nrf2 
was constitutively expressed in OA synovial fibroblasts 
(Figure 6C). These results suggested P-S349 p62 to be 
more involved in synovial fibroblast survival upon BAY 
11-7085 treatment than Nfr2.
Starvation-induced higher MW p62 is reversed 
by albumin to usual MW. PNGase F shifts p62 to 
faster migrating form in human synovial tissue 
extracts
We searched for serum constituent that is able to 
reverse starvation-induced higher MW p62 form. Results 
showed that higher MW p62 form, that appeared within 
minutes of starvation, was rapidly reversed by bovine 
serum albumin (BSA) (Figure 7A, line 6) or human 
serum albumin (results not shown).  In the aim to further 
characterize the p62 MW modification we have treated 
extracts of synovial fibroblasts cultured in the presence 
of MG132 with PNGase F. PNGase F-induced shift 
of p62 (Figure 7B, line 5) also appeared in extracts of 
MG132 treated cells (Figure 7B, line 7). In synovial tissue 
extracts a p62 reacting band (marked by bold arrow) of 
smaller MW than transfected p62 was detected (Figure 
7C, line 1 compared to line 2 and 3). This result suggested 
different p62 alternative splicing [22] in synovial tissue 
and synovial fibroblasts. Calculated  MW of p62 is 47 kDa 
[23] and MW of spliced isoform is 38 kDa [22], but the 
p62 protein, which is thought to have complex covalent 
modifications, migrates at higher MW than 60 kDa 
[23]. PNGase F treatment of synovial tissue extracts 
produced, of interest, faster migrating band, suggesting 
de-glycosylation (Figure 7D, lines 3 and 7 and Figure 7E, 
lines 2 and 4). Specificity of commercially available p62 
antibodies, probably due to different epitope specificity, 
Figure 2: Inhibition of autophagy increases proteasome inhibitor-induced P-S349 p62 stabilization. Human synovial 
fibroblasts were treated with proteasome inhibitor MG132 for 24 hours or concomitantly with MG132 and inhibitor of autophagy MHY 
1485, in the presence or absence of 10% FCS.  Western blots show P-S349 p62, p62, LC3B and GAPDH expressions in human synovial 
fibroblast extracts. Graphics represent average of protein expression from six different experiments done with synovial fibroblasts from six 
different OA patients. Values were calculated as in Figure 1. a* is statistically lower from b*, c* and d*; b* is statistically lower from c*; e* is 
statistically lower from f*, g* and h*; f* is statistically lower from g*; i* is statistically lower from j*.
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was variable (Figure 7E and results not shown). In 
Figure 7E (lines 1–4), both of two different antibodies, 
used for the same synovial tissue extracts, revealed the 
presence of about 50 kDa form (Figure 7E, lines 1 and 3), 
marked with bold arrow, and PNGase F induced down-
shifted form (Figure 7E, lines 2 and 4), marked with 
dashed bold arrow. However, several other p62 like 
forms are detected by the first commercial antibody 
while second commercial antibody detected only 50 
kDa band and its PNGase F induced down-shifted form 
but had low specificity for p62 in synovial fibroblast 
extracts (Figure 7E, lines 5 and 6) and high sensibility 
for transfected p62 (Figure 7C, lines 2 and 3). In contrast, 
first commercial antibody had a strong affinity for p62 
in synovial fibroblasts and it was used for the most 
experiments in this work (Figures 1, 2, 4, 5, 6, 7B, 8). These 
results suggested that p62 is N-glycosylated in synovial 
tissue. In line with this, sequence analysis showed two 
NXS N-glycosylation motifs [24] in human p62 protein: 
NWS at position 205–207 and NCS at position 330–332. 
MG132 stabilizes Endo-β-N-acetylglucosaminidase 
(ENGase) expression and starvation enhances 
ENGase turnover in synovial fibroblasts. NGLY 
co-transfection with p62 or p62 mutants S349A 
and S349E stabilizes p62 in HEK293 cells
Two human de-glycosylation enzymes have been 
cloned and characterized: NGLY1 [19] and ENGase 
[25–27]. To test possible effects of starvation on de-
glycosylation events synovial fibroblasts were cultured 
in the presence or absence of serum and in the presence 
Figure 3: MG132 protects serum cultured and serum starved synovial fibroblasts from BAY 11-7085-induced cell 
death. Human synovial fibroblasts were stimulated with indicated concentrations of MG132 for 24 hours, in the presence or absence of 
serum. BAY 11-7085 was then added for additional 2 hours. Cell survival, estimated by an MTS test, was expressed as a percentage of 
surviving cells compared with control cells. a* is statistically lower than control cells and b*; c* is statistically lower than d* and a*; e* is 
statistically different than control cells, f* and a*; g* is statistically lower than h*, e* and c*.
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of different MG132 concentrations. Cell extracts were 
then tested by Western blot for human ENGase [25] 
(Figure 8A). Results showed that ENGase is expressed in 
synovial fibroblast (Figure 8A, line 1) and that MG132 
stabilizes ENGase expression (Figure 8A, lines 2–6). 
MG132-induced stabilization of ENGase was significantly 
increased during starvation (Figure 8A, line 2 to be 
compared to line 8), suggesting increased turnover of 
ENGase during starvation-induced autophagy.
To test possible involvement of de-glycosylation on 
p62 and P-S349 p62 turnover, we have transfected human, 
HA epitope marked, p62 and its S349A and S349E p62 
mutants [8], having no phosphorylation or constitutive 
mimetic phosphorylation on Serine 349, respectively, 
with human NGLY1 (pNGLY1) (Figure 8B). Results 
showed that pNGLY1 co-transfection, compared to control 
GFP clone (pEGFP-C1), markedly stabilized p62 and its 
mutants (Figure 8B, lines 1–3 compared to lines 4–6). 
Furthermore, pNGLY1 co-transfection also increased p62 
phosphorylation on Serine 349 (Figure 8B, line 1 to be 
compared to line 4 and line 3 to be compared to line 6). 
These results strongly suggested that de-glycosylation 
enzymes are involved in p62 turnover.
DISCUSSION
p62 has been reported to be degraded by autophagy: 
autophagy inhibitors increase p62 protein level [28] and 
p62 accumulates in cells of autophagy-deficient mice [29]. 
However, p62 also participates in UPS. It interacts with 
proteasome and depletion of p62 inhibits UPS [3]. Of 
interest, in neuronal cells p62 is ubiquitinated by Parkin 
on K13 and also degraded by proteasome [30]. MG132-
induced proteasome inhibition results in p62 accumulation 
in human myelomonocyte cell line THP-1 [31]. p62 
is phosphorylated on Serine 349 in Alzheimer disease 
patients [8]. Human SH-SY5Y neuroblastoma cells do not 
express P-Ser349 p62 but accumulates this phosphorylated 
form when stimulated with proteasome or autophagy 
inhibitors [8]. Our results presented here showed that, in 
human synovial fibroblasts, P-Ser349 p62 is degraded 
by both UPS and autophagy, that acted in synergy. We 
have observed previously that MG132 partially rescued 
PPAR γ from BAY 117985-induced degradation [32]. In 
this work, we have tested if MG132 also protects synovial 
fibroblasts from BAY 11-7085-induced cell death. Results 
showed that even nM concentrations of MG132 markedly 
Figure 4: Starvation and PNGase F increase p62 MW and induce RAD23B. Inhibitor of Keap1-P-Ser349 p62 interaction 
and tunicamycin have pro-survival effects on human synovial fibroblasts. (A) Serum cultured synovial fibroblasts from three different 
OA patients were starved for 30 minutes and then 10% FCS was added for additional 5 minutes. Western blots show p62, RAD23B and 
GAPDH expression in synovial fibroblast extracts. Control extracts were treated or not with PNGase F. Dash arrows show higher MW p62 
form. (B) Serum cultured or serum deprived synovial fibroblasts from three different OA patients were cultured in the presence or absence 
of tunicamycin for 48 hours. Western blots show p62 and GAPDH expression in synovial fibroblast extracts. Control extracts were treated 
or not with PNGase F. Dash arrows show higher MW p62 form. (C) Human synovial fibroblasts were cultured in the absence or presence 
of MG132 (0.3 µM) and/or K67 inhibitor (10 µM) or tunicamycin (2 mg/ml) for 24 hours. BAY 11-7085 (10 µM) was then added for 
additional 2 hours. Cell survival, estimated by an MTS test, was expressed as a percentage of surviving cells compared with control cells. 
Oncotarget35836www.oncotarget.com
protected synovial fibroblasts from BAY 11-7085-induced 
cell death. Protein analysis have shown that proteasome 
inhibitors led to P-Ser349 p62 accumulation that cannot 
be otherwise detected in synovial fibroblasts. Of interest, 
P-Ser349 p62 accumulation upon concomitant proteasome 
and autophagy inhibition markedly increased, and 
further increased during serum starvation. These results 
showed that p62 autophagic flux in synovial fibroblasts 
can be measured by P-Ser349 p62 accumulation, 
induced by concomitant cell treatments with nano molar 
concentrations of proteasome inhibitors and micro 
molar concentrations of inhibitors of autophagy. Since 
combination of proteasome and autophagic inhibitors often 
have undesirable toxic effects [33], the use of only nano 
molar concentrations of proteasome inhibitors might be 
also useful in cells other than human synovial fibroblasts. 
P-Ser349 p62 has been reported as accelerator of both 
protein aggregate formation and autophagic clearance 
[33]. Thus, in addition to p62 degradation [15],  P-Ser349 
p62 degradation may be also used as a marker of synovial 
fibroblast autophagy during starvation. 
In this work, we have detected stabilization of 
RAD23B during serum starvation-induced autophagy. 
Rad23B is known for its roles in DNA repair and 
proteasomal degradation [34]. It binds both ubiquitin 
and proteasome, functioning as adaptor protein that itself 
escapes proteasomal degradation [35]. Of interest, Rad23 
is involved in p53 turnover [36]. Coincidence of Rad23B 
up regulation during synovial fibroblast serum starvation, 
as well as its known interaction with NGLY1, suggest 
that RAD23B also may be involved in p62 turnover. 
Marked induction of RAD23B during serum deprivation 
of synovial fibroblast is a phenomena that will be further 
studied in another cell types including cancer cells, in 
which an decrease of RAD23B expression has been 
documented [37, 38]. 
Having interaction with NGLY1, RAD23B, apart 
from its function in DNA repair [39], is involved in 
degradation of misfolded glycoproteins in endoplasmic-
reticulum [17, 40]. NGLY1 is one of de-N-glycosylating 
enzymes, whose activity is not linked to lysosome 
[41, 42], but it is involved in ERAD [26]. Very recently 
it was shown that NGLY1 activates cell protective 
Nrf1 [43]. Furthermore, NGLY1 inhibition inactivated 
Nrf1 and sensitized cells to proteasome inhibition [43]. 
Nrf1 and Nrf2 have both overlapping and distinct roles 
in antioxidant response [44, 45], respectively. S349T 
mutations was found in patient with Paget disease [12, 46]. 
This mutation is in the Keap1 binding region of p62. It 
has been shown that p62 mutated S349T is having less 
interaction with Keap1, less Nrf2 activation and thus links 
Paget disease to Keap1/Nrf2 [12, 47]. In the latest review 
p62 was proposed to be a switch between autophagy, 
apoptosis and cell survival [47]. Our results suggested 
that human p62 could be N-glycosylated because PNGase 
F converted synovial tissue extracts p62 into faster 
Figure 5: Phosphorylation-mimetic p62 mutant of Serine 349 (S349E), but not phosphorylation-defective mutant 
(S349A) or wild type (WT) p62, protects OA synovial fibroblasts from BAY 11 7085-induced cell death. Synovial 
fibroblasts were transduced with lentivirus carrying HA tagged phosphorylation-mimetic (S349E) mutant, phosphorylation-defective 
(S349A) mutant, WT p62 or GFP control. After five days of infection BAY 11-7085 was added at indicated concentrations for additional 
2 hours. Cell survival was determined by MTS test. (A) Western blots represent expression of p62, HA epitope and GAPDH in cell extracts 
of one representative experiment, after five days of infection, before BAY 11-7085 treatment. (B) Cell survival of the lentivirus transduced 
OA synovial fibroblasts shown in (A), after BAY 11-7085 treatment. Results of MTS test are shown as relative quantity of formazan in cell 
supernatant (OD490). a* is statistically different from BAY 11-7085 treated control cells (expressing GFP). (C) % of cell survival compared 
to control cells (expressing GFP) and calculated as average values for three different OA patients transduced with lentivirus at 25 MOI. a* 
is statistically different from b*. 
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form, although this effect was not confirmed in isolated 
synovial fibroblasts. The reason for this discrepancy 
may lay in p62 alternative splicing [22]. Furthermore, 
PNGase F increased p62 molecular weight in isolated 
synovial fibroblasts. Similarly, not yet understandable 
increase of Npr1 molecular weight upon endo H treatment 
has been shown previously [48]. Two NXS motifs are 
present in human p62 protein: NWS at position 205–207 
and NCS at position 330–332. These motifs represent 
potential N-glycosylation sites. These results suggested 
de-glycosylation events to be directly and/or indirectly, 
involved in p62 turnover. We thus overexpressed p62 with 
NGLY1 and found that NGLY1 markedly increases p62 
expression in HEK293 cells, suggesting that NGLY1 is 
involved in p62 turnover. The future research is needed to 
distinguish if NGLY1 transfection have direct or indirect 
de-glycosylation effects on p62 or NGLY1 increases 
expression efficiency by anti-apoptotic effects [49]. Of 
interest, very recently, NGLY1 has been shown to de-
glycosylate Nrf1 and change its turnover and function 
[43]. Furthermore, we have shown here that human 
ENGase [25, 27] turnover is significantly enhanced in 
starved human synovial fibroblasts. ENGase are distinct 
glycanase from NGLY1, that leaves N-acetylglucosamine 
attached to the deglycosylated protein. However, deletion 
of ENGase, can partially rescue lethality of NGLY1 
deficient mice [27]. Further studies are needed to test how 
de-glycosylation events are involved in p62 fate.  
Proteasome inhibitors can rescue cells from oxidative 
stress [50] as well as from apoptosis [9, 51]. In multiple 
myeloma UPS inhibitors are used as a treatment but many 
patients fail to respond due to p62 accumulation during 
proteasomal stress [52]. In our experimental model, we have 
detected p62 as cytoprotective protein during proteasome 
inhibition, but we cannot exclude Nrf2, mainly described as 
cytoprotective protein too [53]. We showed in this work that 
Nrf2 expression increased in MG132-treated OA human 
synovial fibroblasts, but that phosphorylated Nrf2 (Serine 
40), an activated form of Nrf2 [21], was constitutively 
expressed in these cells.  Also, very recently it was shown 
that BAY 11-7085 toxic effect in cancer cells include Nrf2 
[54]. To distinguish p62 and Nrf2 effects, we have used 
K67, an Nrf2 inhibitor [20]. K67 inhibits Keap1-p-Ser349 
p62 interaction and increases Nfr2 turnover [10, 20]. Our 
Figure 6: Partial knock-down of p62 does not change human synovial fibroblast fate upon BAY 11-7085 treatment. 
Nrf2 is constitutively phosphorylated on Serine 40 in OA synovial fibroblasts. Synovial fibroblasts from two different OA patients were 
transduced with lentivirus carrying p62 shRNA or (non-targeting) NT shRNA as control, for five days. (A) Western blots show p62 and 
GAPDH expressions in cell extracts from two different OA patients. (B) After five days of lentvirus infection, BAY 11-7085 was added for 
additional 2 hours and MTS tests performed. Graphics show cell survival (% of control cells) of each donor cells, that were transduced with 
lentivirus carrying p62 shRNA or NT shRNA (50 MOI). (C) Synovial fibroblasts were cultured with different concentrations of MG132, in 
the presence or absence of serum, for 24 hours. Western blots show expression of P-S349 p62, p62, Nrf2, Nrf2 phosphorylated on Serine 
40 and GAPDH in cell extracts of one representative OA patient. Experiments were repeated three times with cells from three different 
OA patients. 
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results showed that K67 had synergistic effect with low, sub 
protective concentration of MG132 to significantly protect 
synovial fibroblasts from BAY 11-7085-induced cell death. 
Furthermore, we showed here that lentivirus mediated 
overexpression of p62 S349E phosphorylation mimetic 
mutant significantly protect synovial fibroblasts from BAY 
11-7085-induced cell death. In contrast, phosphorylation 
defective p62 S349A did not have protective effect but, 
of interest, wild type p62 neither. These results further 
confirmed important role of P-S349 p62 in OA synovial 
fibroblast survival. Similar results were obtained previously 
in human Huh7 and Hepa1 liver cell lines [10]. These 
cell lines are protected from Sorafenib- and Cisplatin-
induced cell death when transduced by adenovirus carrying 
mouse phospho-mimetic p62 S351E (corresponding to 
human S349E) mutant, but not with mouse p62 defective 
phosphorylation p62 S351A mutant (corresponding to 
human S349A) or mouse wild type p62 [10]. 
Benefic effects of MG132 treatment has been shown 
in mice model of adjuvant arthritis [55] and mice model 
of collagen-induced arthritis [56]. Very recently, activation 
of p62-Keap1-Nrf2 axis was shown to suppress collagen-
induced arthritis in mice through P-S349 p62 [13]. These 
results suggest that proteasome inhibitors may also 
activate p62-Keap1-Nrf2 axis in vivo. Indeed, proteasome 
inhibition in mice liver increase both autophagy and 
Keap1/Nrf2 pathway [57]. We showed in this work that 
proteasome inhibitor MG132 stabilized P-S349 p62 in 
synovial fibroblasts and that P-S349 p62 stabilization 
further increased during serum starvation as well as with 
concomitant inhibition of autophagy. Concomitant use of 
proteasome and autophagy inhibitors might act in synergy 
to stabilize P-S349 p62 in vivo too.
MATERIALS AND METHODS
Cell isolation and culturing
Human primary synovial fibroblasts from 
osteoarthritis (OA) patients were isolated and cultured 
as explained previously [14]. Serum cultured or serum 
deprived synovial fibroblasts were stimulated for 24 hours 
Figure 7: Bovine serum albumin reverses higher MW of p62 to usual MW. PNGase F transforms p62 to de-glycosylation-like 
form with lower MW in human synovial tissue extracts. (A) Synovial fibroblasts were starved for 30 minutes and then 10% FCS or BSA (23 
mg/ml) were added for additional 5 minutes. Western blot shows p62 expression detected with p62 (PW9860), Enzo Life Sciences. Dash 
arrow shows higher MW p62 form. (B) Synovial fibroblasts were cultured with or without serum, in the presence or absence of MG132, 
for 24 hours. Denaturated cell extracts were treated or not with PNGase F. Western show P-Ser349 p62, p62 (detected with p62/SQSTM1 
(P0067), Sigma-Aldrich) and GAPDH expressions. (C) Western blot showing p62 detected in human synovial tissue and in serum cultured 
and serum starved HEK293 cells transfected with p62 [58]. p62 was detected by anti-SQSTM1/p62 (D5E2) (#8025), Cell Signaling. Dash 
arrow shows higher MW p62 form. Bold arrow shows p62 in synovial tissue. (D) Extracts of human synovial tissue were treated or not with 
PNGase F or with O-Glycosidase and Neuraminidase. Western blots show p62 and α-Tubulin expressions in human synovial tissue extracts 
of two OA patients. p62 was detected with anti-SQSTM1/p62 (D5E2) (#8025), Cell Signaling. Bold dashed arrow shows de-glycosylation 
like p62 form. (E) Comparison of p62 detection in extracts from human synovial tissue with p62/SQSTM1 (P0067), Sigma-Aldrich) (lines 
1, 2) and anti-SQSTM1/p62 (D5E2) (#8025), Cell Signaling (lines 3, 4). Lines 5, 6: human synovial fibroblast extracts. All extracts were 
denaturated and treated or not with PNGase F. Dashed bold arrow shows de-glycosylation-like p62 form of smaller MW.
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with proteasome inhibitor MG132 (CAS 133407-82-6), 
Calbiochem, and/or autophagy inhibitor, mTOR agonist 
MHY1485 (500554), or inhibitor of Keap1-P-Ser349 p62 
interaction, K67 (SML 1922), Sigma. In some experiments 
an IkBα inhibitor BAY 11-7085 (Alexis Corp., San Diego, 
CA) was added for additional 2 hours. For autophagic 
flux determination [15], serum cultured or serum starved 
synovial fibroblasts were treated with Bafilomycin A1 
(Sigma) for 24 hours.
Western blotting
Human primary synovial fibroblasts and HEK293 
cells were collected on ice in lysis buffer [32]. Human 
synovial tissue was cut, freezed and macerated in cold 
lysis buffer. Western blotting was done as explained 
previously [14, 32], by the use of following primary 
antibodies: p62/SQSTM1 (P0067), LC3B (L7543), 
GAPDH (G9545), α-Tubulin (T9026), Sigma-Aldrich, 
p62 (PW9860), Enzo Life Sciences, SQSTM1/p62 (D5E2) 
(#8025), RAD23B (D4W7F) (#13525), Cell Signaling, 
Phospho-p62 (SQSTM1) (Ser351) (M217-3), MBL, 
NGLY1 (A305-547A-T) Bethyl Laboratories, Inc., GFP 
(Y1030), UBPBio, ENGase (PA5-24531), Thermo Fisher 
Scientific, Nrf2 (MAB3925), R&D, and Nrf2 (Phospho 
S40) [EP1809Y] (ab76026), Abcam.  Rabbit (#7074) 
and mouse (#7076) secondary antibodies were from Cell 
Signaling and mouse IgG2b (Star 134) from AbD Serotec.
De-glycosylation tests
Cell and tissue extracts were denaturated and treated 
with PNGase F (P0704) or O-glycosidase (P0733) plus 
neuraminidase (P0720), New England BioLabs, for 1–3 h 
at 37° C, according to the manufacturer’s instructions. 
Survival assay
Synovial fibroblasts were stimulated with different 
concentrations of proteasome inhibitor MG132 (CAS 
133407-82-6), Calbiochem, for 24 hours and then BAY 
11-7085 (Alexis Corp., San Diego, CA) was added for 
additional 2 hours. Survival assay, MTS (Promega, 
Madison, WI), was then performed for additional hour, 
according to the manufacturer’s instructions. Cell survival 
was expressed as a percentage of surviving cells compared 
with control cells.
Plasmids and DNA transfection
Human p62, cloned in pcDNA3.1 [58] was kindly 
provided by Dr Franco Venanzi, University of Camerino; 
HA tagged human p62, p62-HA, and its phosphorylation 
Figure 8: Starvation increases ENGase turnover in synovial fibroblasts. Co-transfection of NGLY1 with p62 increases p62 
expression in HEK293 cells. (A) Synovial fibroblasts were cultured with or without serum, in the presence of different concentrations of 
MG132 as indicated. Western blots show ENGase and GAPDH expressions in synovial fibroblast extracts. Graphics represent average of 
protein expression from three different experiments done with synovial fibroblasts from three different OA patients. Values were calculated 
as in Figure 1. a* and b* are significantly higher than controls.  a* is significantly lower from b*. (B) p62-HA or p62-HA mutant S349A that 
has no phosphorylation on Serine 349 or p62-HA mutant S349E that has constitutive mimetic phosphorylation on Serine 349 (8) are co-
transfected with NGLY1 or pEGFP-C1 into HEK293 cells. Western blots show P-S349 p62, p62, GFP, NGLY1 and GAPDH expressions 
in HEK293 extracts. 
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mutants Ser349A (phosphorylation defective) and Ser349E 
(phosphorylation mimetic) [8] were kindly provided by Dr 
Kunikazu Tanji, University of Hirosaki. Human NGLY1 
cDNA, cloned in pCMV3 expression plasmid (HG15563-
UT), was from Sino Biological Inc [59]. pEGFP-C1 was 
from Clontech. For transfection, HEK293 cells were 
seeded in 6-wells plates (BD Biosciences) (28 × 104 
cells/ 2 ml of culturing medium). Cells were transfected with 
3 mg of DNA by the use of linear polyethyleneimine (MW 
25,000) (Polysciences, Inc., Warrington, PA). 
Lentivirus transduction
For lentivirus transduction experiments, we 
created three gene transfer lentiviral plasmids by re-
cloning of p62-HA, its phosphorylation mimetic mutant 
S349E and phosphorylation defective mutant S349A 
[8] as HindIII (blunted with T4 DNA polymerase)/XhoI 
fragment to EcoRV/XhoI sites of pLenti6/V5-D-TOPO 
vector (Invitrogen), that was previously modified by 
introduction of additional multiple cloning sites. EGFP 
cloned into pLenti6/V5-D-TOPO was used as control. 
Gene transfer lentiviral plasmid used for p62 (SQSTM1) 
knock-down experiments were pLV U6 shRNA hSQSTM1 
#7235 (Hygro) (#180615-1046feu) (target sequence: 
CAGATGAGAAAGATCGCCTT) and non-targeting 
control pLV U6 shRNA NT (Hygro) (#VB180316-
1189paa) (Vector Builder).
Lentivirus production was done by our GIGA Viral 
Vectors platform. Briefly, Lenti-X 293T cells (632180), 
Clontech, were co-transfected with gene transfer lentiviral 
plasmids, pSPAX2, Addgene and VSV-G encoding 
plasmid [60]. Viral supernatants were collected 48, 72 
and 96 hours post transfection, filtrated (0.2 µM) and 
concentrated (100×) by ultracentrifugation. Titration was 
done with qPCR Lentivirus Titration (Titer) Kit (ABM). 
For infection experiments human synovial 
fibroblasts were plated into 96-wells plates and day after 
inoculated with lentiviruses caring p62-HA, p62 (S349E), 
p62 (S349A), EGFP, shRNA p62 or non-targeting NT 
shRNA, at a multiplicity of infection (MOI) of 5–50. 
After 5 days of infection BAY 11-7085 was added for 
2 hours and then MTS was performed. In parallel, synovial 
fibroblasts were plated into 24-wells plates and day after 
infected with lentiviruses caring p62-HA, p62 (S349E), 
p62 (S349A), EGFP, p62 shRNA or NT shRNA, at 5–50 
MOI. After 5 days of infection cells were recuperated in 
lysis buffer [32] and analyzed by Western blot.
Statistical analysis
p values were obtained using the Mann–Whitney test 
and Student’s t-test. Values of p < 0.05 were considered as 
statistically significant.
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